{"title":"Towards policy impact - an exploration of <i>Clinical Toxicology</i> research cited in policy documents and patents.","authors":"Lisa Schölin, Michael Eddleston","doi":"10.1080/15563650.2024.2398136","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Individual researcher impact through scientific citations is carefully monitored, with little attention to the impact of individual journals through policy and patent mentions. We aimed to describe policy and patent mentions for articles published in <i>Clinical Toxicology</i>.</p><p><strong>Methods: </strong>Using Altmetric Explorer, we extracted mentions from 1 January 2013 to 31 December 2023, noting the citing source, <i>Clinical Toxicology</i> article title, and author-generated keywords. We used descriptive statistics to analyse the data.</p><p><strong>Results: </strong>We identified 165 individual policy documents (<i>n</i> = 139) and patents (<i>n</i> = 26), citing 146 articles with median of 6.4 years between publication and mention. The highest number of citing documents were by the World Health Organization (<i>n</i> = 45), European Monitoring Centre for Drugs and Drug Addiction (<i>n</i> = 22), and United States Centers for Disease Control and Prevention (<i>n</i> = 16). Most patents were registered in the United States (<i>n</i> = 17) and by the European Patent Office (<i>n</i> = 10), with the main classification of human necessities (<i>n</i> = 23). The commonest subjects of papers cited in policy and patents, from keywords, related to medical conditions and symptoms (26%) and recreational drugs (22%). The most cited article was \"A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.\"</p><p><strong>Discussion: </strong><i>Clinical Toxicology</i> articles are cited in policy documents and patents, with a comparable number of mentions to the top-ranked journals in the field. This likely contributes to policy impact, but further work is needed to understand how cited articles are used and ripple effects through onwards citations of policy documents.</p><p><strong>Conclusions: </strong><i>Clinical Toxicology</i> is a toxicology journal for which published research gets recognised within influential policy sources. The Journal can play a key role in guiding public health policy through its selection and development of submitted publications.</p>","PeriodicalId":10430,"journal":{"name":"Clinical Toxicology","volume":" ","pages":"636-642"},"PeriodicalIF":3.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15563650.2024.2398136","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Individual researcher impact through scientific citations is carefully monitored, with little attention to the impact of individual journals through policy and patent mentions. We aimed to describe policy and patent mentions for articles published in Clinical Toxicology.
Methods: Using Altmetric Explorer, we extracted mentions from 1 January 2013 to 31 December 2023, noting the citing source, Clinical Toxicology article title, and author-generated keywords. We used descriptive statistics to analyse the data.
Results: We identified 165 individual policy documents (n = 139) and patents (n = 26), citing 146 articles with median of 6.4 years between publication and mention. The highest number of citing documents were by the World Health Organization (n = 45), European Monitoring Centre for Drugs and Drug Addiction (n = 22), and United States Centers for Disease Control and Prevention (n = 16). Most patents were registered in the United States (n = 17) and by the European Patent Office (n = 10), with the main classification of human necessities (n = 23). The commonest subjects of papers cited in policy and patents, from keywords, related to medical conditions and symptoms (26%) and recreational drugs (22%). The most cited article was "A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment."
Discussion: Clinical Toxicology articles are cited in policy documents and patents, with a comparable number of mentions to the top-ranked journals in the field. This likely contributes to policy impact, but further work is needed to understand how cited articles are used and ripple effects through onwards citations of policy documents.
Conclusions: Clinical Toxicology is a toxicology journal for which published research gets recognised within influential policy sources. The Journal can play a key role in guiding public health policy through its selection and development of submitted publications.
期刊介绍：
clinical Toxicology publishes peer-reviewed scientific research and clinical advances in clinical toxicology. The journal reflects the professional concerns and best scientific judgment of its sponsors, the American Academy of Clinical Toxicology, the European Association of Poisons Centres and Clinical Toxicologists, the American Association of Poison Control Centers and the Asia Pacific Association of Medical Toxicology and, as such, is the leading international journal in the specialty.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
